A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Completed · Phase 1

Conditions studied: HIV Infections, HIV Seronegativity

In brief

The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.

Key facts

Study ID

NCT00004579

Run by

Walter Reed Army Institute of Research (WRAIR)

Starts

1998-04-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Volunteers may be eligible for this study if they:
• Are HIV-negative.
• Are in good health.
• Are between ages 18 and 55.
• Are available for at least 1 year.
• Are a resident of the United States of America.
• Agree to practice sexual abstinence or use birth control.

You may not qualify if…

• Volunteers will not be eligible for this study if they:
• Have ever been given an HIV vaccine or certain other vaccines. (However, rabies vaccines are allowed.)
• Participate in activities that place them at high-risk for HIV infection, such as injection drug use or unprotected sex with someone who has HIV infection.
• Have certain psychiatric, medical, or substance abuse problems.
• Are allergic to eggs or other vaccines.
• Are an employee at a participating site and have access to study information.
• Are taking certain medications.
• Have received blood transfusions within 3 months before entering this study.
• Are pregnant or breast-feeding.

Where it is running

• Walter Reed Army Institute of Research — Rockville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.